Global Blockchain in Pharmaceutical 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI09242379

Publication Date:

September 23, 2024

Pages:

109

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Blockchain in Pharmaceutical market size was valued at US$ 1706.1 million in 2023. With growing demand in downstream market, the Blockchain in Pharmaceutical is forecast to a readjusted size of US$ 2174.6 million by 2030 with a CAGR of 3.5% during review period.
The research report highlights the growth potential of the global Blockchain in Pharmaceutical market. Blockchain in Pharmaceutical are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Blockchain in Pharmaceutical. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Blockchain in Pharmaceutical market.
The global Blockchain in Pharmaceutical market size is projected to reach US$ 30519 million by 2026, from US$ 1010.2 million in 2019, at a CAGR of 72.77% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Blockchain in Pharmaceutical market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Blockchain in Pharmaceutical market in terms of revenue.
Among the different types of blockchain in pharmaceutical, the private blockchain held the maximum market share with about 91% in 2019.
For applications of the blockchain in pharmaceutical, the supply chain logistics is the largest segment with a market share of nearly 69% in 2019.
Key Features:
The report on Blockchain in Pharmaceutical market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Blockchain in Pharmaceutical market. It may include historical data, market segmentation by Type (e.g., Public Blockchain, Private Blockchain), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Blockchain in Pharmaceutical market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Blockchain in Pharmaceutical market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Blockchain in Pharmaceutical industry. This include advancements in Blockchain in Pharmaceutical technology, Blockchain in Pharmaceutical new entrants, Blockchain in Pharmaceutical new investment, and other innovations that are shaping the future of Blockchain in Pharmaceutical.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Blockchain in Pharmaceutical market. It includes factors influencing customer ' purchasing decisions, preferences for Blockchain in Pharmaceutical product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Blockchain in Pharmaceutical market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Blockchain in Pharmaceutical market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Blockchain in Pharmaceutical market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Blockchain in Pharmaceutical industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Blockchain in Pharmaceutical market.
麻豆原创 Segmentation:
Blockchain in Pharmaceutical market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Public Blockchain
Private Blockchain
Segmentation by application
Supply Chain Management
Drug Development
Clinical Trials
Internet of Medical Things (IOMT) & Cyber Security
Other Applications
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
IBM
AWS
Microsoft
SAP
Chronicled
Doc.AI
Embleema
Factom Inc.
FarmaTrust
Guardtime Federal
Hashed Health
Medicalchain
Huawei

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Blockchain in Pharmaceutical 麻豆原创 Size 2019-2030
2.1.2 Blockchain in Pharmaceutical 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Blockchain in Pharmaceutical Segment by Type
2.2.1 Public Blockchain
2.2.2 Private Blockchain
2.3 Blockchain in Pharmaceutical 麻豆原创 Size by Type
2.3.1 Blockchain in Pharmaceutical 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Blockchain in Pharmaceutical 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Blockchain in Pharmaceutical Segment by Application
2.4.1 Supply Chain Management
2.4.2 Drug Development
2.4.3 Clinical Trials
2.4.4 Internet of Medical Things (IOMT) & Cyber Security
2.4.5 Other Applications
2.5 Blockchain in Pharmaceutical 麻豆原创 Size by Application
2.5.1 Blockchain in Pharmaceutical 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Blockchain in Pharmaceutical 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Blockchain in Pharmaceutical 麻豆原创 Size by Player
3.1 Blockchain in Pharmaceutical 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Blockchain in Pharmaceutical Revenue by Players (2019-2024)
3.1.2 Global Blockchain in Pharmaceutical Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Blockchain in Pharmaceutical Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Blockchain in Pharmaceutical by Regions
4.1 Blockchain in Pharmaceutical 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Blockchain in Pharmaceutical 麻豆原创 Size Growth (2019-2024)
4.3 APAC Blockchain in Pharmaceutical 麻豆原创 Size Growth (2019-2024)
4.4 Europe Blockchain in Pharmaceutical 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Blockchain in Pharmaceutical 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Blockchain in Pharmaceutical 麻豆原创 Size by Country (2019-2024)
5.2 Americas Blockchain in Pharmaceutical 麻豆原创 Size by Type (2019-2024)
5.3 Americas Blockchain in Pharmaceutical 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blockchain in Pharmaceutical 麻豆原创 Size by Region (2019-2024)
6.2 APAC Blockchain in Pharmaceutical 麻豆原创 Size by Type (2019-2024)
6.3 APAC Blockchain in Pharmaceutical 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Blockchain in Pharmaceutical by Country (2019-2024)
7.2 Europe Blockchain in Pharmaceutical 麻豆原创 Size by Type (2019-2024)
7.3 Europe Blockchain in Pharmaceutical 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Blockchain in Pharmaceutical by Region (2019-2024)
8.2 Middle East & Africa Blockchain in Pharmaceutical 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Blockchain in Pharmaceutical 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Blockchain in Pharmaceutical 麻豆原创 Forecast
10.1 Global Blockchain in Pharmaceutical Forecast by Regions (2025-2030)
10.1.1 Global Blockchain in Pharmaceutical Forecast by Regions (2025-2030)
10.1.2 Americas Blockchain in Pharmaceutical Forecast
10.1.3 APAC Blockchain in Pharmaceutical Forecast
10.1.4 Europe Blockchain in Pharmaceutical Forecast
10.1.5 Middle East & Africa Blockchain in Pharmaceutical Forecast
10.2 Americas Blockchain in Pharmaceutical Forecast by Country (2025-2030)
10.2.1 United States Blockchain in Pharmaceutical 麻豆原创 Forecast
10.2.2 Canada Blockchain in Pharmaceutical 麻豆原创 Forecast
10.2.3 Mexico Blockchain in Pharmaceutical 麻豆原创 Forecast
10.2.4 Brazil Blockchain in Pharmaceutical 麻豆原创 Forecast
10.3 APAC Blockchain in Pharmaceutical Forecast by Region (2025-2030)
10.3.1 China Blockchain in Pharmaceutical 麻豆原创 Forecast
10.3.2 Japan Blockchain in Pharmaceutical 麻豆原创 Forecast
10.3.3 Korea Blockchain in Pharmaceutical 麻豆原创 Forecast
10.3.4 Southeast Asia Blockchain in Pharmaceutical 麻豆原创 Forecast
10.3.5 India Blockchain in Pharmaceutical 麻豆原创 Forecast
10.3.6 Australia Blockchain in Pharmaceutical 麻豆原创 Forecast
10.4 Europe Blockchain in Pharmaceutical Forecast by Country (2025-2030)
10.4.1 Germany Blockchain in Pharmaceutical 麻豆原创 Forecast
10.4.2 France Blockchain in Pharmaceutical 麻豆原创 Forecast
10.4.3 UK Blockchain in Pharmaceutical 麻豆原创 Forecast
10.4.4 Italy Blockchain in Pharmaceutical 麻豆原创 Forecast
10.4.5 Russia Blockchain in Pharmaceutical 麻豆原创 Forecast
10.5 Middle East & Africa Blockchain in Pharmaceutical Forecast by Region (2025-2030)
10.5.1 Egypt Blockchain in Pharmaceutical 麻豆原创 Forecast
10.5.2 South Africa Blockchain in Pharmaceutical 麻豆原创 Forecast
10.5.3 Israel Blockchain in Pharmaceutical 麻豆原创 Forecast
10.5.4 Turkey Blockchain in Pharmaceutical 麻豆原创 Forecast
10.5.5 GCC Countries Blockchain in Pharmaceutical 麻豆原创 Forecast
10.6 Global Blockchain in Pharmaceutical Forecast by Type (2025-2030)
10.7 Global Blockchain in Pharmaceutical Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 IBM
11.1.1 IBM Company Information
11.1.2 IBM Blockchain in Pharmaceutical Product Offered
11.1.3 IBM Blockchain in Pharmaceutical Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 IBM Main Business Overview
11.1.5 IBM Latest Developments
11.2 AWS
11.2.1 AWS Company Information
11.2.2 AWS Blockchain in Pharmaceutical Product Offered
11.2.3 AWS Blockchain in Pharmaceutical Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 AWS Main Business Overview
11.2.5 AWS Latest Developments
11.3 Microsoft
11.3.1 Microsoft Company Information
11.3.2 Microsoft Blockchain in Pharmaceutical Product Offered
11.3.3 Microsoft Blockchain in Pharmaceutical Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Microsoft Main Business Overview
11.3.5 Microsoft Latest Developments
11.4 SAP
11.4.1 SAP Company Information
11.4.2 SAP Blockchain in Pharmaceutical Product Offered
11.4.3 SAP Blockchain in Pharmaceutical Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 SAP Main Business Overview
11.4.5 SAP Latest Developments
11.5 Chronicled
11.5.1 Chronicled Company Information
11.5.2 Chronicled Blockchain in Pharmaceutical Product Offered
11.5.3 Chronicled Blockchain in Pharmaceutical Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Chronicled Main Business Overview
11.5.5 Chronicled Latest Developments
11.6 Doc.AI
11.6.1 Doc.AI Company Information
11.6.2 Doc.AI Blockchain in Pharmaceutical Product Offered
11.6.3 Doc.AI Blockchain in Pharmaceutical Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Doc.AI Main Business Overview
11.6.5 Doc.AI Latest Developments
11.7 Embleema
11.7.1 Embleema Company Information
11.7.2 Embleema Blockchain in Pharmaceutical Product Offered
11.7.3 Embleema Blockchain in Pharmaceutical Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Embleema Main Business Overview
11.7.5 Embleema Latest Developments
11.8 Factom Inc.
11.8.1 Factom Inc. Company Information
11.8.2 Factom Inc. Blockchain in Pharmaceutical Product Offered
11.8.3 Factom Inc. Blockchain in Pharmaceutical Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Factom Inc. Main Business Overview
11.8.5 Factom Inc. Latest Developments
11.9 FarmaTrust
11.9.1 FarmaTrust Company Information
11.9.2 FarmaTrust Blockchain in Pharmaceutical Product Offered
11.9.3 FarmaTrust Blockchain in Pharmaceutical Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 FarmaTrust Main Business Overview
11.9.5 FarmaTrust Latest Developments
11.10 Guardtime Federal
11.10.1 Guardtime Federal Company Information
11.10.2 Guardtime Federal Blockchain in Pharmaceutical Product Offered
11.10.3 Guardtime Federal Blockchain in Pharmaceutical Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Guardtime Federal Main Business Overview
11.10.5 Guardtime Federal Latest Developments
11.11 Hashed Health
11.11.1 Hashed Health Company Information
11.11.2 Hashed Health Blockchain in Pharmaceutical Product Offered
11.11.3 Hashed Health Blockchain in Pharmaceutical Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Hashed Health Main Business Overview
11.11.5 Hashed Health Latest Developments
11.12 Medicalchain
11.12.1 Medicalchain Company Information
11.12.2 Medicalchain Blockchain in Pharmaceutical Product Offered
11.12.3 Medicalchain Blockchain in Pharmaceutical Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 Medicalchain Main Business Overview
11.12.5 Medicalchain Latest Developments
11.13 Huawei
11.13.1 Huawei Company Information
11.13.2 Huawei Blockchain in Pharmaceutical Product Offered
11.13.3 Huawei Blockchain in Pharmaceutical Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 Huawei Main Business Overview
11.13.5 Huawei Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.